4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-045358
Chief Executive Officer bought 3,800 shares at $0.26 ($1,003)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Yuval Chief Executive Officer | 2022-08-10 | Purchase | +3,800 | $0.26 | $1,003 | 98,230 | D: show line 1 in the form |
| Open-market purchases · 3,800 sh · avg $0.26 · $1,003 | |||||||
Loading xslF345X03/doc4.xml…